ArticleCancer immunology, immunotherapy : CII2017

A case of pembrolizumab-induced type-1 diabetes mellitus and discussion of immune checkpoint inhibitor-induced type 1 diabetes.

Young Kwang Chae et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.